Memphasys Ltd (AU:MEM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Memphasys Ltd has extended its Share Purchase Plan closing date to October 31, 2024, following shareholder feedback requesting more time to consider the offer. The initiative aims to raise up to $3 million, funding projects like the Felix clinical trial and equine fertility study. This extension provides investors additional opportunities to engage with Memphasys’ promising biotechnology advancements.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.